Mapping Bromodomains in breast cancer and association with clinical outcome

Por Pérez-Pena, Javier, Páez, Raquel, Nieto-Jiménez, Cristina, Sánchez, Verónica Corrales, Galan-Moya, Eva M., Pandiella, Atanasio, Győrffy, Balázs, Ocana, Alberto
Publicado no Sci Rep (2019)

Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene

Por Noblejas-López, María del Mar, Morcillo-García, Sara, Nieto-Jiménez, Cristina, Nuncia-Cantarero, Miriam, Győrffy, Balázs, Galan-Moya, Eva M., Pandiella, Atanasio, Ocaña, Alberto
Publicado no PLoS One (2018)

The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity

Por Dwyer, Julie, Azzi, Sandy, Leclair, Héloïse M, Georges, Steven, Carlotti, Agnès, Treps, Lucas, Galan-Moya, Eva M, Alexia, Catherine, Dupin, Nicolas, Bidère, Nicolas, Gavard, Julie
Publicado no Cell Commun Signal (2015)

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

Por Noblejas-López, María del Mar, Nieto-Jimenez, Cristina, Burgos, Miguel, Gómez-Juárez, Mónica, Montero, Juan Carlos, Esparís-Ogando, Azucena, Pandiella, Atanasio, Galán-Moya, Eva M., Ocaña, Alberto
Publicado no J Exp Clin Cancer Res (2019)

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer

Por Corrales‐Sánchez, Verónica, Noblejas‐López, María del Mar, Nieto‐Jiménez, Cristina, Pérez‐Peña, Javier, Montero, Juan Carlos, Burgos, Miguel, Galán‐Moya, Eva M., Pandiella, Atanasio, Ocaña, Alberto
Publicado no J Cell Mol Med (2020)

Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors

Por Morcillo-Garcia, Sara, Noblejas-Lopez, Maria del Mar, Nieto-Jimenez, Cristina, Perez-Peña, Javier, Nuncia-Cantarero, Miriam, Győrffy, Balázs, Amir, Eitan, Pandiella, Atanasio, Galan-Moya, Eva M., Ocana, Alberto
Publicado no PLoS One (2019)

Expression of MHC class I, HLA-A and HLA-B identifies immune-activated breast tumors with favorable outcome

Por Noblejas-López, María del Mar, Nieto-Jiménez, Cristina, Morcillo García, Sara, Pérez-Peña, Javier, Nuncia-Cantarero, Miriam, Andrés-Pretel, Fernando, Galán-Moya, Eva M., Amir, Eitan, Pandiella, Atanasio, Győrffy, Balázs, Ocana, Alberto
Publicado no Oncoimmunology (2019)

Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors

Por Nieto-Jiménez, Cristina, Alcaraz-Sanabria, Ana, Pérez-Peña, Javier, Corrales-Sánchez, Verónica, Serrano-Heras, Gemma, Galán-Moya, Eva M., Serrano-Oviedo, Leticia, Montero, Juan Carlos, Burgos, Miguel, Llopis, Juan, Pandiella, Atanasio, Ocaña, Alberto
Publicado no Oncotarget (2017)

Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer

Por Niza, Enrique, Noblejas-López, María del Mar, Bravo, Iván, Nieto-Jiménez, Cristina, Castro-Osma, José Antonio, Canales-Vázquez, Jesús, Lara-Sanchez, Agustín, Galán Moya, Eva M., Burgos, Miguel, Ocaña, Alberto, Alonso-Moreno, Carlos
Publicado no Nanomaterials (Basel) (2019)

Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC

Por Galan-Moya, Eva M., de la Cruz-Morcillo, Miguel A., Valero, Maria Llanos, Callejas-Valera, Juan L., Melgar-Rojas, Pedro, Losa, Javier Hernadez, Salcedo, Mayte, Fernández-Aramburo, Antonio, Cajal, Santiago Ramon y., Sánchez-Prieto, Ricardo
Publicado em 2011

ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy

Por Aceves-Luquero, Clara I., Agarwal, Anupriya, Callejas-Valera, Juan L., Arias-González, Laura, Esparís-Ogando, Azucena, del Peso Ovalle, Luis, Bellón-Echeverria, Itxaso, de la Cruz-Morcillo, Miguel A., Galán Moya, Eva M., Gimeno, Inmaculada Moreno, Gómez, Juan C., Deininger, Michael W., Pandiella, Atanasio, Prieto, Ricardo Sánchez
Publicado em 2009